Jan 14, 2021 / 01:20PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. I'm Robbie Marcus, med tech analyst at JPMorgan. Very happy to introduce our next session, which is Integra LifeSciences. We're going to have CEO, Pete Arduini, during the presentation. We'll have the management team join us after. Before I hand it over, everybody can go to the conference website to grab their slides. Can ask a question there or e-mail me or chat me on Bloomberg, and I'll do my best to get to all of them in the Q&A session. So with that, Pete, I'm going to hand it over to you, and I'll see you for Q&A.
Peter J. Arduini - Integra LifeSciences Holdings Corporation - President, CEO & Director
Thanks, Robbie, and good morning, everyone. The presentation, the first 2 to 3 pages, we actually have our safe harbor and looking forward statements. You can see those for your review on Pages 2 and 3.
But let's start the presentation. And if you turn to Slide 4 in the slide deck titled Integra at a Glance, I'll start there. We are a global
Integra Lifesciences Holdings Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot